Monte Rosa Therapeutics, Inc. (GLUE)
24.00
+0.28
(+1.18%)
USD |
NASDAQ |
Jan 13, 16:00
24.00
0.00 (0.00%)
After-Hours: 20:00
Monte Rosa Therapeutics Total Liabilities (Quarterly): 214.00M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 638.39M |
| CorMedix, Inc. | 376.73M |
| Indivior PLC | 1.623B |
| Mirum Pharmaceuticals, Inc. | 493.07M |
| Innovative Eyewear, Inc. | 0.925M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 459.84M |
| Shareholders Equity (Quarterly) | 245.84M |
| Debt to Equity Ratio | 0.1634 |
| Current Ratio | 6.540 |
| Net Debt Paydown Yield | 0.18% |